keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 228.00 | |
5 mg | In stock | $ 572.00 | |
10 mg | In stock | $ 913.00 | |
25 mg | In stock | $ 1,730.00 | |
50 mg | In stock | $ 2,790.00 | |
100 mg | In stock | $ 3,770.00 |
Description | Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling. |
Synonyms | JNJ-64251330 |
Molecular Weight | 408.5 |
Formula | C22H28N6O2 |
CAS No. | 2230282-02-5 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL(244.80 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lorpucitinib 2230282-02-5 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK JNJ-64251330 inhibitor inhibit